Process View
16 genes annotated in human
DOID:0080014
A genetic disease that has material basis in extra, missing, or re-arranged chromosomes.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "chromosomal disease"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RORA | RAR-related orphan receptor A | 0.855 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.706 | ||
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.623 | ||
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.387 | Human | |
| EID1 | EP300 interacting inhibitor of differentiation 1 | 0.354 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.250 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.192 | Human | |
| KRTAP4-12 | keratin associated protein 4-12 | 0.107 | ||
| MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.099 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.066 | ||
| PHF17 | PHD finger protein 17 | 0.061 | ||
| GATA4 | GATA binding protein 4 | 0.046 | Human | |
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.046 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.043 | ||
| TUBB8 | tubulin, beta 8 | 0.039 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.039 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.036 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.035 | ||
| TBC1D14 | TBC1 domain family, member 14 | 0.030 | ||
| HDAC4 | histone deacetylase 4 | 0.030 | ||
| AFTPH | aftiphilin | 0.029 | ||
| PCGF2 | polycomb group ring finger 2 | 0.027 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.024 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.022 | ||
| GATA2 | GATA binding protein 2 | 0.018 | Human | |
| RUNX1 | runt-related transcription factor 1 | 0.018 | ||
| CASC3 | cancer susceptibility candidate 3 | 0.016 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.015 | ||
| C11orf49 | chromosome 11 open reading frame 49 | 0.015 | ||
| PRKG2 | protein kinase, cGMP-dependent, type II | 0.014 | ||
| NOMO2 | NODAL modulator 2 | 0.014 | ||
| MDFI | MyoD family inhibitor | 0.013 | ||
| TRIM65 | tripartite motif containing 65 | 0.013 | ||
| IRS1 | insulin receptor substrate 1 | 0.012 | ||
| FKBP5 | FK506 binding protein 5 | 0.012 | ||
| TBX1 | T-box 1 | 0.012 | ||
| AMHR2 | anti-Mullerian hormone receptor, type II | 0.011 | ||
| HSPA1L | heat shock 70kDa protein 1-like | 0.011 | ||
| EID2B | EP300 interacting inhibitor of differentiation 2B | 0.011 | ||
| ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.011 | ||
| ZBTB4 | zinc finger and BTB domain containing 4 | 0.011 | ||
| SIN3B | SIN3 homolog B, transcription regulator (yeast) | 0.011 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.010 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.009 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.008 | ||
| DHH | desert hedgehog | 0.007 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.006 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.005 | ||
| SNRPN | small nuclear ribonucleoprotein polypeptide N | 0.003 | ||
| NDN | necdin homolog (mouse) | 0.003 | ||
| CDKL5 | cyclin-dependent kinase-like 5 | 0.003 | ||
| SRY | sex determining region Y | 0.002 | ||
| CBX2 | chromobox homolog 2 | 0.002 | ||
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.001 | ||
| RBM8A | RNA binding motif protein 8A | 0.000 | ||
| UBE3A | ubiquitin protein ligase E3A | 0.000 |